Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

David R Powell, Deon Doree, Sabrina Jeter-Jones, Zhi-Ming Ding, Brian Zambrowicz, Arthur Sands Lexicon Pharmaceuticals, The Woodlands, TX, USA Purpose: Oral agents are needed that improve glycemic control without increasing hypoglycemic events in patients with type 1 diabetes (T1D). Sotagliflozin m...

Full description

Bibliographic Details
Main Authors: Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Diabetes, Metabolic Syndrome and Obesity
Online Access:http://www.dovepress.com/sotagliflozin-improves-glycemic-control-in-nonobese-diabetes-prone-mic-peer-reviewed-article-DMSO

Internet

http://www.dovepress.com/sotagliflozin-improves-glycemic-control-in-nonobese-diabetes-prone-mic-peer-reviewed-article-DMSO

Similar Items